Page 10 - 80 guidelines for the treatment of malaria_opt

nd
Guidelines for the treatment of malaria – 2 edition

abbreviations

ACT artemisinin-based combination therapy
AL artemether plus lumefantrine combination
AQ amodiaquine
AS artesunate
AS+AQ artesunate plus amodiaquine combination
AS+MQ artesunate plus mefloquine combination
AS+SP artesunate plus sulfadoxine-pyrimethamine combination
BW body weight
CI confidence interval
CQ chloroquine
DHA+PPQ dihydroartemisinin plus piperaquine combination
EIR entomological inoculation rate
GRADE Grading of Recommendations Assessment, Development
and Evaluation
G6PD glucose-6-phosphate dehydrogenase
HIV/AIDS human immunodeficiency virus/
acquired immunodeficiency syndrome
HRP2 histidine-rich protein 2
IC 50 concentration providing 50% inhibition
IV intravenous
IM intramuscular
MIC minimum inhibitory concentration
MQ mefloquine
OR odds ratio
PCR polymerase chain reaction
PfHRP2 Plasmodium falciparum histidine-rich protein-2
pLDH parasite-lactate dehydrogenase
PQ primaquine
Pvdhfr Plasmodium vivax dihydrofolate reductase
RCT randomized controlled trial
RDT rapid diagnostic test
RR relative risk
SP sulfadoxine-pyrimethamine
WHO World Health Organization
WMD weighted mean difference

viii